← All companies

GH

Guardant Health, Inc.

GH Nasdaq Services-Medical Laboratories EDGAR ↗

$158.83

+6.48 +4.25%

Key statistics

from XBRL data in SEC filings

Market cap

$21.3B

Revenue (TTM)

$1.18B

Net income (TTM)

-$453M

EPS (TTM)

$-3.50

P/E ratio

—

Dividend yield

—

Free cash flow

-$233M

Cash

$1.05B

Total assets

$1.91B

Gross margin

—

52-week range

$41.19 – $176.58

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Shareholder vote results Jun 18, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change Apr 27, 2026 10-K Fiscal year ended 2025-12-31 Feb 19, 2026 8-K Results of operations (earnings release) Feb 19, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Nov 7, 2025 10-Q Quarter ended 2025-09-30 Oct 29, 2025 8-K Results of operations (earnings release) Oct 29, 2025 8-K Regulation FD disclosure Sep 24, 2025 8-K Director or officer change Sep 15, 2025 10-Q Quarter ended 2025-06-30 Jul 30, 2025 8-K Results of operations (earnings release) Jul 30, 2025 8-K Shareholder vote results Jun 20, 2025 10-Q Quarter ended 2025-03-31 Apr 30, 2025 8-K Results of operations (earnings release) Apr 30, 2025 8-K Entered a material agreement; Took on a direct financial obligation Apr 9, 2025 10-K Fiscal year ended 2024-12-31 Feb 20, 2025 8-K Results of operations (earnings release) Feb 20, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Feb 14, 2025 8-K Entered a material agreement; Unregistered sale of equity Feb 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Director or officer change Oct 24, 2024 8-K Entered a material agreement Aug 23, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Other events Jul 29, 2024 8-K Director or officer change Jul 18, 2024 8-K Shareholder vote results Jun 14, 2024 8-K Director or officer change May 31, 2024 8-K Other events May 24, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Director or officer change Mar 22, 2024 10-K Fiscal year ended 2023-12-31 Feb 22, 2024